|
| Home : Luye Pharma's Goserelin Acetate Extended-release Microspheres Start Phase III Clinical Trials in China, Paralleling Smooth Progress with U.S. Regulators |
|
Sep 07
2018 |
Luye Pharma's Goserelin Acetate Extended-release Microspheres Start Phase III Clinical Trials in China, Paralleling Smooth Progress with U.S. Regulators |
|
SHANGHAI, Sept. 7, 2018 /PRNewswire/ -- On September 4, Luye Pharma announced that its independently developed drug, Goserelin Acetate Extended-release Microspheres for Injection (LY01005), has entered phase III clinical trials for prostate cancer in China. Meanwhile, LY01005 is currently ... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/luye-pharmas-goserelin-acetate-extended-release-microspheres-start-phase-iii-clinical-trials-in-china-paralleling-smooth-progress-with-us-regulators-300708679.html |
| |
|
Related News
|
» AIMC organiza la firma local de la carta global Responsible Care® y la ceremonia de clausura abierta al público
» Trump attacks Democrats for 'sick' attacks against Judge Kavanaugh
|
|
|
